Scientific Council Review
February 28, 2023
Susan Hiniker, MD, Assistant Professor and Director of the Pediatric Radiation Oncology Program, has received approval from the Children's Oncology Group (COG) Scientific Council for the concept summary ARST23P1, "Catequentinib (Anlotinib) in Combination with Stereotactic Body Radiation Therapy (SBRT) in Children and Young Adults with Relapsed/Refractory Nonrhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)." This is a significant achievement for Dr. Hiniker and for Stanford Radiation Oncology. This is the first time a radiation oncologist has led a soft tissue sarcoma study as principal investigator that has received COG Scientific Council approval, and one of the first COG studies led by a radiation oncologist in any discipline to receive Scientific Council approval. Congratulations, Dr. Hiniker, for this significant COG achievement!